一种临床上无声的抵抗表型,促进了Acinetobacter baumannii在胆固醇治疗期间的生存
bioRxiv : the preprint server for biology
|February 6, 2026
概括
临床无声耐药性 (CSR) 允许Acinetobacter baumannii在科里斯治疗中存活下来,即使在看起来敏感时也是如此. 这种MIC独立的生存状态影响了难以治疗的感染的治疗结果.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 宝曼尼菌 (Acinetobacter baumannii) 是多种耐药性医院感染的重要原因,特别是与呼吸机相关的肺炎.
- 胆固醇是A. baumannii的最后避险抗生素,但尽管确定的耐药性率低,但临床结果是可变的.
- 在用胆固醇治疗期间使细菌能够存活的细菌机制尚不清楚.
研究的目的:
- 为了研究A. baumannii.中的胆固醇蛋白反应的遗传基础.
- 为了确定细菌在胆固醇治疗期间生存的策略.
- 了解标准抗生素敏感性测试在预测临床结果方面的局限性.
主要方法:
- 监督机器学习用于候选基因的基因组优先级.
- 功能和生理测试来评估细菌的健康状况.
- 使用小鼠肺炎模型进行体内研究.
- 标准化抗生素敏感性测试 (MIC确定).
主要成果:
- 机器学习识别了与胆固醇存活相关的遗传位置,许多不影响最小抑制度 (MIC).
- 一个子组突变体表现出临床静态耐药性 (CSR),在素暴露期间保持健康,尽管被归类为敏感.
- 在小鼠肺炎模型中,CSR突变体在胆固醇治疗期间表现出增强的存活率和增殖率.
结论:
- 临床无声耐药性 (CSR) 是A. baumannii的一种新型,MIC独立的生存机制.
- 标准敏感性测试未能检测到CSR,突出了预测治疗疗效的局限性.
- 了解企业社会责任对于改善针对多药耐药性A. baumannii感染的治疗策略至关重要.
更多相关视频
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
1.3K
08:37The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
2.6K
相关概念视频
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
The Eukaryotic Promoter Region
18.9K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
Survival Curves
721
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
721
Survival Tree
433
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
433
Introduction To Survival Analysis
798
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
798
Comparing the Survival Analysis of Two or More Groups
605
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
605
